Anesthetic Agents and Induction Risks

Barbiturate for Electroconvulsive Therapy (ECT)
Common Classes of Anesthetic Induction Agents
Periods of Highest Myocardial Infarction (MI) Risk

A patient is most vulnerable to a myocardial infarction at two critical junctures:

Importance of Limiting Peri-Induction Stress
Anesthesia Induction Considerations for Asthmatic Patients
Patients at Elevated Risk for Aspiration During Induction

Five categories of patients have a higher likelihood of aspirating stomach contents into the lungs:

Alternate Term for Cricoid Pressure

Pain Management and Pharmaceutical Agents

Pain Scale Selection
Examples of Opioid Analgesics

These potent pain medications include:

Opioid Causing Nausea/Vomiting (N/V)
Opioids Causing Chest Wall Rigidity/Respiratory Distress
Advantages of Hydromorphone/Fentanyl over Morphine
Sole Approved Use for Meperidine (Demerol)
Opioid Reversal Agent and Dosing
Benzodiazepines: Uses and Limitations
Examples of Benzodiazepines and Reversal Agent
Midazolam (Versed) vs. Diazepam (Valium) Preference
Flumazenil (Romazicon): Reversal Agent and Contraindications
Key Concern with Benzodiazepines

Holistic Therapy Rights

Muscle Relaxants

Only Depolarizing Paralytic
Mechanism of Action: Succinylcholine
Pros and Cons of Succinylcholine
Patients Who Should Never Receive Depolarizing Paralytics
Succinylcholine Reversal
Depolarizing vs. Non-Depolarizing Muscle Relaxants (NDMRs): Mechanism
Speed of Action: Depolarizing vs. NDMRs
Reversibility of Muscle Relaxants
Reasons to Choose an NDMR Over a Depolarizing Relaxant (4)
  1. Family history of Malignant Hyperthermia (MH).
  2. Presence of degenerative muscle disorders (MS, MD, Myasthenia Gravis, Cerebral Palsy, paraplegia).
  3. Known pseudocholinesterase deficiency.
  4. Need for prolonged paralysis during surgery.
NDMR Reversal Agents and Administration Timing
Side Effects of NDMR Reversal Agents (Anticholinesterases)
NDMR Reversal Agent Combinations
Succinylcholine Reversal (Incorrect Statement)
Sugammadex: Unique NDMR Reversal Agent

Inhalation Anesthetics

Reasons Halothane is No Longer Used
Reasons Isoflurane is Less Commonly Used
Drug of Choice for Inhaled Induction
List of Inhalation Gas Options (6)
Inhalation Gas Contraindicated in Seizure Patients
Desflurane: Pros and Cons
Inhalation Gas to Avoid in Airway Surgery
Post-Operative Considerations with Nitrous Oxide Use
Waste Anesthetic Gas (WAG) System
OR Air Exchanges
Concerns with Patients Exhaling Anesthetic Gas

Malignant Hyperthermia (MH)

Determining MH Risk
Individuals Most at Risk for MH
Pathophysiology of MH Crisis
Triggers for MH Episode

Two conditions must be met for an MH episode:

  1. A genetically susceptible patient.
  2. Exposure to a triggering agent (Succinylcholine/depolarizing agents, or volatile liquid inhalants).
Earliest Consistent Indicator of MH Crisis
Early vs. Late Indicators of MH Crisis
Focus During an MH Episode
Steps for MH Crisis Management (Comprehensive Protocol)
  1. Eliminate the Trigger: Immediately stop the triggering agent. Turn off all volatile gases. Flush the anesthesia machine system and change the breathing circuit. Nitrous oxide may be safely used.
  2. Hyperventilate with Oxygen: Provide 100% oxygen and hyperventilate as rapidly and as much as physiologically possible.
  3. Call for Expert Consultation: Contact MHAUS (Malignant Hyperthermia Association of the United States) at 1-800-MH-HYPER.
  4. Administer Dantrolene:
    • Dose: 2.5 mg/kg (range 2-3 mg/kg) mixed ONLY with preservative-free sterile water.
    • Preparation: Withdraw 60 mL of sterile water, add to the Dantrolene vial, reconstitute, then withdraw and administer.
    • Ryanodex: A newer, more concentrated powdered Dantrolene; only requires 1 vial and is more expensive.
  5. Treat Metabolic Acidosis: Administer intravenous sodium bicarbonate to counteract lactic acidosis and help the liver process it.
  6. Manage Hyperkalemia: Treat with insulin, glucose/D50 (to prevent hypoglycemia), and calcium (to stabilize cardiac membranes and mitigate cardiac effects of hyperkalemia, such as arrhythmias and QT prolongation).
  7. Address Myoglobinuria: Administer diuretics and fluids to prevent kidney damage.
  8. Cool the Patient: Apply ice packs and a cooling blanket. Use iced normal saline IV fluids (avoid LR as it contains potassium and lactate).
  9. Monitor Labs and ECG: Regularly check electrolytes and perform ECGs for arrhythmias.
  10. Post-Crisis Care: Transfer the patient to the ICU for prolonged monitoring (longer than 24 hours) as MH can recur.
Dantrolene Dose and Preparation
Average Dantrolene Dose for Adults
Hyperkalemia Treatment in MH Crisis
Medications to AVOID During MH Crisis
Most Effective Ways to Warm a Patient